Audio Feature: FDA Monitoring Cosmetic Claims, But Litigation Remains Biggest Threat
This article was originally published in The Rose Sheet
Executive Summary
Attorney Steven Shapiro, a partner at Ullman, Shapiro & Ullman, LLP, offers perspective on what he considers some of the biggest challenges cosmetics companies face in the current regulatory and legal landscape, specifically when it comes to crafting claims. Story features audio clips from the attorney’s interview with “The Rose Sheet.”
You may also be interested in...
FTC Action On 'All Natural' Claims Likely To 'Embolden' Plaintiffs
Attorneys agree that FTC's announced settlements with personal-care companies for misleading "all-natural" claims likely will not be helpful to class-action defendants making primary-jurisdiction arguments and could actually spur more litigation, similar to trends following FDA warning letters.
FTC Action On 'All Natural' Claims Likely To 'Embolden' Plaintiffs
Attorneys agree that FTC's announced settlements with personal-care companies for misleading "all-natural" claims likely will not be helpful to class-action defendants making primary-jurisdiction arguments and could actually spur more litigation, similar to trends following FDA warning letters.
FTC Action Against 'All Natural' Claims Likely To 'Embolden' Plaintiffs
Attorneys agree that FTC's announced settlements with personal-care companies for misleading "all-natural" claims likely will not be helpful to class-action defendants making primary-jurisdiction arguments and could actually spur more litigation, similar to trends following FDA warning letters.